Mesenchymal Stem Cell Alongside Exosomes As a Novel Cell-based Therapy for COVID-19: A Review Study

Overview

Journal Clin Immunol

Specialty Allergy & Immunology

Date 2021 Mar 8

PMID 33684527

Citations 18

Authors

Meruyert Dauletova

Hafsan Hafsan

Negah Mahhengam

Angelina Olegovna Zekiy

Majid Ahmadi

Homayoon Siahmansouri

Affiliations

Soon will be listed here.

Abstract

In the past year, an emerging disease called Coronavirus disease 2019 (COVID-19), caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been discovered in Wuhan, China, which has become a worrying pandemic and has challenged the world health system and economy. SARS-CoV-2 enters the host cell through a specific receptor (Angiotensin-converting enzyme 2) expressed on epithelial cells of various tissues. The virus, by inducing cell apoptosis and production of pro-inflammatory cytokines, generates as cytokine storm, which is the major cause of mortality in the patients. This type of response, along with responses by other immune cell, such as alveolar macrophages and neutrophils causes extensive damage to infected tissue. Newly, a novel cell-based therapy by Mesenchymal stem cell (MSC) as well as by their exosomes has been developed for treatment of COVID-19 that yielded promising outcomes. In this review study, we discuss the characteristics and benefits of MSCs therapy as well as MSC-secreted exosome therapy in treatment of COVID-19 patients.

Citing Articles

Feline coronavirus influences the biogenesis and composition of extracellular vesicles derived from CRFK cells.

Wijerathne S, Pandit R, Ipinmoroti A, Crenshaw B, Matthews Q Front Vet Sci. 2024; 11:1388438.

PMID: 39091390 PMC: 11292801. DOI: 10.3389/fvets.2024.1388438.

Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19.

Hou X, Danzeng L, Wu Y, Ma Q, Yu Z, Li M World J Stem Cells. 2024; 16(4):353-374.

PMID: 38690515 PMC: 11056634. DOI: 10.4252/wjsc.v16.i4.353.

Bone Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Lipopolysaccharide-Induced Lung Injury Via the miR-21-5p/PCSK6 Pathway.

Cai B, Song W, Chen S, Sun J, Zhou R, Han Z J Immunol Res. 2023; 2023:3291137.

PMID: 37937296 PMC: 10626970. DOI: 10.1155/2023/3291137.

Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19.

Zendedel E, Tayebi L, Nikbakht M, Hasanzadeh E, Asadpour S Curr Stem Cell Res Ther. 2023; 19(8):1055-1071.

PMID: 37815188 DOI: 10.2174/011574888X260032230925052240.

Key Role of Mesenchymal Stromal Cell Interaction with Macrophages in Promoting Repair of Lung Injury.

Jerkic M, Szaszi K, Laffey J, Rotstein O, Zhang H Int J Mol Sci. 2023; 24(4).

PMID: 36834784 PMC: 9965074. DOI: 10.3390/ijms24043376.

References

Yin K, Wang S, Zhao R . Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomark Res. 2019; 7:8. PMC: 6450000. DOI: 10.1186/s40364-019-0159-x. View

Li X, Liu Y, Li J, Sun L, Yang J, Xu F . Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2. Immunol Res. 2020; 68(6):398-404. PMC: 7521864. DOI: 10.1007/s12026-020-09156-2. View

Kaneko Y, Nimmerjahn F, Ravetch J . Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006; 313(5787):670-3. DOI: 10.1126/science.1129594. View

Sims A, Baric R, Yount B, Burkett S, Collins P, Pickles R . Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol. 2005; 79(24):15511-24. PMC: 1316022. DOI: 10.1128/JVI.79.24.15511-15524.2005. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Li J, Wei L, Han Z, Chen Z . Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 2019; 852:68-76. DOI: 10.1016/j.ejphar.2019.01.022. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

He X, Dong Z, Cao Y, Wang H, Liu S, Liao L . MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing. Stem Cells Int. 2019; 2019:7132708. PMC: 6754952. DOI: 10.1155/2019/7132708. View

Lamichhane P, Samarasinghe A . The Role of Innate Leukocytes during Influenza Virus Infection. J Immunol Res. 2019; 2019:8028725. PMC: 6757286. DOI: 10.1155/2019/8028725. View

10.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

11.

Haider K, Aramini B . Mircrining the injured heart with stem cell-derived exosomes: an emerging strategy of cell-free therapy. Stem Cell Res Ther. 2020; 11(1):23. PMC: 6953131. DOI: 10.1186/s13287-019-1548-7. View

12.

Yao X, Li T, He Z, Ping Y, Liu H, Yu S . [A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua Bing Li Xue Za Zhi. 2020; 49(5):411-417. DOI: 10.3760/cma.j.cn112151-20200312-00193. View

13.

Thevarajan I, Nguyen T, Koutsakos M, Druce J, Caly L, van de Sandt C . Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020; 26(4):453-455. PMC: 7095036. DOI: 10.1038/s41591-020-0819-2. View

14.

Valizadeh H, Abdolmohammadi-Vahid S, Danshina S, Gencer M, Ammari A, Sadeghi A . Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol. 2020; 89(Pt B):107088. PMC: 7574843. DOI: 10.1016/j.intimp.2020.107088. View

15.

Hemmat N, Derakhshani A, Baghi H, Silvestris N, Baradaran B, De Summa S . Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study. Front Genet. 2020; 11:641. PMC: 7296827. DOI: 10.3389/fgene.2020.00641. View

16.

Golchin A, Farahany T . Biological Products: Cellular Therapy and FDA Approved Products. Stem Cell Rev Rep. 2019; 15(2):166-175. DOI: 10.1007/s12015-018-9866-1. View

17.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

18.

Cong J, Wei H . Natural Killer Cells in the Lungs. Front Immunol. 2019; 10:1416. PMC: 6603080. DOI: 10.3389/fimmu.2019.01416. View

19.

Yang L, Peng H, Zhu Z, Li G, Huang Z, Zhao Z . Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clin Immunol. 2006; 120(2):171-8. PMC: 7106132. DOI: 10.1016/j.clim.2006.05.002. View

20.

Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020; 26(8):1200-1204. DOI: 10.1038/s41591-020-0965-6. View